Top Articles - Finance

Using this method of charitable giving, you can actually give your assets away and keep them. It's like having your cake and eating it, too!

Most people who take the time to plan their estate already have a str

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ong sense of family and community and want to leave gifts to their favorite charities. Many estate planning attorneys are familiar with charitable planning which is important because of the complex nature of the

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

charitable giving provisions of the Internal Revenue Code.

A Fundamental Aspect

Charitable giving has always been a fundamental aspect of estate planning. Most people who plan have a strong sense of fa

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ily and community and are therefore inclined to make charitable gifts a part of an overall estate plan.

Many estate planning attorneys have a good deal of knowledge about charitable planning. This knowledge is

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

extremely important given the complex nature of the charitable giving provisions of the Internal Revenue Code.

A Complexity of Issues

Charitable planning is not an area that should be approached lightly

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

There are a myriad of issues that must be considered, including control; income, gift, and estate tax ramifications; current finances; future income and principal needs; the extent of your charitable inclinatio

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

n; and the types of property you own.

The simplest way to give to a charity is by making an outright gift. Outright gifts can be made either during a person's lifetime or at death. Donors of charitable gifts ge

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

erally receive tax benefits. The availability and amount of those benefits depend on several factors, and the charitable gift must be properly structured to maximize the tax advantages.

Q. Can I actually "ma

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ke money" by giving to charity?

A. If you have any charitable interest to help, for example, the church you attend, the school or college from which you or your children graduated, or the hospital where lov

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

d ones have been cared for- then you can "profit" from the pleasure you'll derive by helping a charitable organization you believe in to carry out its worthwhile mission.

Q. I would like to make a charitable

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

contribution, but I do not have the financial means available to me. Are there any alternatives?

A. Outright gifts during life can be made only by persons who can afford to do so. However, charitable givin

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

g can include split-interest trusts. These are special trusts which provide both a benefit to a charity and a benefit to a "non-charity." This non-charity is generally the donor and the donor's family.

Split-in

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

erest trusts have gained popularity because they can satisfy personal financial needs as well as philanthropic desires. The most commonly used split-interest trust is the charitable remainder trust. A less frequ

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ently used split-interest trust is the charitable lead trust.

What Is A CRT?

A charitable remainder trust (CRT) is an irrevocable trust created for the purpose of holding assets given to the trus

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

by a donor during the donor's lifetime or upon the donor's death.

A charitable remainder trust is a split interest trust. Its donated assets are shared the charity and the other beneficiaries. Typicall

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

y, a CRT is designed to pay income to the trust's beneficiaries who are not the charity, usually the donor and the donor's spouse, for life or for a term of years. At their death or the designated term of years,

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

the trust assets are paid to (or held for) qualified charitable beneficiaries.

At least 5 % of the trusts assets must be paid as income each year. There is no limit as to the number or type of income beneficiar

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ies (individuals, corporations, trusts, etc.), except that at least one income beneficiary must be a taxable entity.

A CRT can continue for the lifetimes of the persons selected as income beneficiaries or for a

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

term of up to 20 years. When the last income beneficiary dies or the term of years expires, all assets remaining in the trust must be distributed to one or more charities, called charitable remaindermen.

In thi

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

s way the donated assets may provide a steady income at reduced tax rate for you as the donor/beneficiary and ultimately benefit your chosen charities as well. You will truly have your cake and eat it too!

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Top Articles - Charitable Remainder Trust - Having Your Cake & Eating It Too

Related Articles: